Glenn Goddard

Glenn Goddard is the EVP and CFO of Intellia Therapeutics. Glenn has over 20 years of experience in finance and accounting.

Glenn began their career at Ernst & Young as an audit senior. Glenn then joined Feeley & Driscoll, P.C., where they became an audit supervisor. In 2000, they moved to Dragon Systems as their accounting manager.

In 2001, Glenn joined ImmunoGen as their controller. Glenn was with the company for two years before moving to Archemix in 2004, where they became the VP of finance. Glenn held this position for six years until they joined Agios in 2010 as their SVP of finance.

Glenn remained with Agios until 2017, when they joined Generation Bio as their CFO. Glenn was with Generation Bio for just over a year before moving to Intellia Therapeutics in 2018.

Their manager is John Leonard, President & CEO. They are on a team with Ian Karp - SVP, Investor Relations and Corporate Communications, Aron Stein - SVP, Regulatory Affairs, and David Lebwohl - EVP, Chief Medical Officer.